Evolution of the Average Target: Stride, Inc.

Evolution of the Target Price: Stride, Inc.

Changes in Analyst Recommendations: Stride, Inc.

fa93b70fc07a157631.cSZIUT3lwTnh89v_rIIFxhdKrOGTTFTvGyiVJ55gSIg.B044PUWK8FSWxIKJwfhAh1QYn5LZJBGIcEDmcvUlO_4CFyIZDKv5WqmVvA~48d67871337f3f8fabbb3d823830d8e6
01/08 Stride Shares Fall After William Blair Downgrade MT
31/07 William Blair Downgrades Stride to Market Perform From Outperform MT
29/25/29 Morgan Stanley Lowers Price Target on Stride to $130 From $159, Keeps Equalweight Rating MT
29/25/29 BMO Capital Downgrades Stride to Market Perform From Outperform, Adjusts PT to $108 From $164 MT
06/25/06 Analyst recommendations: Micron, Nike, Stellantis, Microsoft, Newmont Corp… Zonebourse
29/25/29 Barrington Raises Price Target on Stride to $185 From $170, Keeps Outperform Rating MT
06/25/06 Morgan Stanley Raises Price Target on Stride to $159 From $148, Keeps Equalweight Rating MT
06/25/06 Stride Q4 revenue, adjusted EPS beat estimates RE
30/25/30 Barrington Research Adjusts Stride's Price Target to $170 From $150, Keeps Outperform Rating MT
30/25/30 Morgan Stanley Raises Price Target on Stride to $148 From $141, Keeps Equalweight Rating MT
21/25/21 Stride Positioned for 'Beat, Raise' in Fiscal Q3 Amid Strong Enrollments, Morgan Stanley Says MT
21/25/21 Morgan Stanley Raises Price Target on Stride to $141 From $117, Keeps Equalweight Rating MT
29/25/29 Barrington Adjusts Price Target on Stride to $140 From $130, Maintains Outperform Rating MT
23/24/23 Morgan Stanley Raises Price Target on Stride to $94 From $74, Keeps Equalweight Rating MT
21/24/21 Stride Shares Fall After Citigroup Downgrade MT
20/24/20 Citigroup Downgrades Stride to Neutral From Buy, Adjusts Price Target to $90 From $77 MT
08/24/08 Barrington Research Adjusts Stride's PT to $90 From $85, Keeps Outperform Rating MT
08/24/08 Canaccord Genuity Initiates Coverage on Stride With Buy Rating, $94 Price Target MT
31/24/31 Barrington Research Adjusts Stride's Price Target to $85 From $75, Keeps Outperform Rating MT
24/24/24 Morgan Stanley Raises Price Target on Stride to $70 From $65, Cites 'Solid Quarter,' Keeps Equalweight Rating MT
25/24/25 BMO Capital Adjusts Price Target on Stride to $72 From $71, Keeps Outperform Rating MT
25/24/25 Barrington Ups Price Target on Stride to $75 From $70 as Fiscal Q2 Results Surpass Estimates, Maintains Outperform Rating MT
24/24/24 Barrington Research Adjusts Stride's Price Target to $75 From $70, Maintains Outperform Rating MT
16/23/16 BMO Capital Adjusts Stride's Price Target to $67 From $57, Maintains Outperform Rating MT
16/23/16 Morgan Stanley Adjusts Price Target on Stride to $60 From $57, Maintains Equal-Weight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+40.08%
+37.99%
+10.26%
+20.93%
+34.2%
+15.18%
+30.27%
- - +38.02%
+36.29%
Average +29.25%
Weighted average by Cap. +29.60%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
83.67USD
Average target price
109.00USD
Spread / Average Target
+30.27%
High Price Target
125.00USD
Spread / Highest target
+49.40%
Low Price Target
93.00USD
Spread / Lowest Target
+11.15%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

William Blair & Co.
BMO Capital
Morgan Stanley
Barrington Research
Citigroup
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
83.67USD
Average target price
109.00USD
Spread / Average Target
+30.27%

Quarterly revenue - Rate of surprise